3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Dermatologic
1
Conditions
Lung Neoplasms
51
Leukemia, Myeloid, Acute
47
Neoplasm Metastasis
44
Carcinoma, Non-Small-Cell Lung
37
Breast Neoplasms
37
Prostatic Neoplasms
31
Multiple Myeloma
30
Pancreatic Neoplasms
27
Colorectal Neoplasms
27
Carcinoma, Renal Cell
24
Melanoma
23
Ovarian Neoplasms
21
Lymphoma
21
Burkitt Lymphoma
21
Leukemia, Lymphocytic, Chronic, B-Cell
19
Triple Negative Breast Neoplasms
18
Myelodysplastic Syndromes
18
Urinary Bladder Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Squamous Cell Carcinoma of Head and Neck
14
Glioblastoma
14
Fallopian Tube Neoplasms
14
Carcinoma, Hepatocellular
14
Oropharyngeal Neoplasms
13
Glioma
13
Sarcoma
12
Mouth Neoplasms
12
Endometrial Neoplasms
12
Carcinoma
12
Interventions
pembrolizumab
8
cemiplimab
5
Nivolumab
4
Ipilimumab
4
Blood Specimen Collection
3
lifileucel
2
avelumab
2
aldesleukin
2
Niacinamide
2
Cyclophosphamide
2
toripalimab
1
tislelizumab
1
oxycodone-acetaminophen
1
lenvatinib
1
fludarabine
1
epacadostat
1
encorafenib
1
durvalumab
1
dostarlimab
1
brodalumab
1
binimetinib
1
atezolizumab
1
Vitamin A
1
Surgical Procedures, Operative
1
Sunscreening Agents
1
Standard of Care
1
Specimen Handling
1
Resistance Training
1
Radiotherapy
1
Niacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Specimen Handling
×
90 days
×
Clear all
NCT07062003
2026-06-04
MBRT1
Mayo Clinic
Phase NA
Recruiting
60 enrolled